Product NDC: | 55154-4510 |
Proprietary Name: | DYAZIDE |
Non Proprietary Name: | hydrochlorothiazide and triamterene |
Active Ingredient(s): | 25; 37.5 mg/1; mg/1 & nbsp; hydrochlorothiazide and triamterene |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-4510 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016042 |
Marketing Category: | NDA |
Start Marketing Date: | 19940330 |
Package NDC: | 55154-4510-1 |
Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (55154-4510-1) |
NDC Code | 55154-4510-1 |
Proprietary Name | DYAZIDE |
Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (55154-4510-1) |
Product NDC | 55154-4510 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydrochlorothiazide and triamterene |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19940330 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | HYDROCHLOROTHIAZIDE; TRIAMTERENE |
Strength Number | 25; 37.5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |